ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,284.91
0.20%
Dow Jones
42,219.40
0.73%
Gold vs US Dollar
2,670.575
0.50%
Brent Oil
70.985
-3.01%
Bitcoin
65,258.83
3.37%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) News

Cue Biopharma (CUE)

Cue Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CUE
DateTimeSourceHeadlineSymbolCompany
10/09/202421:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CUECue Biopharma Inc
09/09/202413:00GlobeNewswire Inc.Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business OfficerNASDAQ:CUECue Biopharma Inc
05/09/202421:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
05/09/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/09/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
03/09/202413:00GlobeNewswire Inc.Cue Biopharma to Present at The Promise of Interleukin-2 Therapy ConferenceNASDAQ:CUECue Biopharma Inc
28/08/202421:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CUECue Biopharma Inc
19/08/202421:05GlobeNewswire Inc.Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
16/08/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
14/08/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
13/08/202413:00GlobeNewswire Inc.Cue Biopharma to Host Business Update Call and WebcastNASDAQ:CUECue Biopharma Inc
25/07/202421:05GlobeNewswire Inc.Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital RequirementsNASDAQ:CUECue Biopharma Inc
25/07/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
07/06/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
07/06/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
07/06/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
07/06/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
07/06/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
04/06/202413:00GlobeNewswire Inc.Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual MeetingNASDAQ:CUECue Biopharma Inc
03/06/202413:00GlobeNewswire Inc.Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024NASDAQ:CUECue Biopharma Inc
24/05/202421:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CUECue Biopharma Inc
09/05/202421:05GlobeNewswire Inc.Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
09/05/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
09/05/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
08/05/202413:00GlobeNewswire Inc.Cue Biopharma to Present at the 20th Annual PEGS Boston SummitNASDAQ:CUECue Biopharma Inc
07/05/202413:00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences ConferenceNASDAQ:CUECue Biopharma Inc
24/04/202415:01GlobeNewswire Inc.Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CUECue Biopharma Inc
08/04/202421:05GlobeNewswire Inc.Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business HighlightsNASDAQ:CUECue Biopharma Inc
02/04/202413:00GlobeNewswire Inc.Cue Biopharma to Host Business Update Call and WebcastNASDAQ:CUECue Biopharma Inc
08/03/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:CUE

Your Recent History

LSE
SYME
Supply@me Capital
LSE
AGL
Angle
LSE
ENET
Ethernity Networks
LSE
VAST
Vast Resources
LSE
GGP
Greatland Gold
LSE
PXC
Phoenix Copper
LSE
AAZ
Anglo Asian Mining
LSE
PANR
Pantheon Resources
LSE
GEX
Georgina Energy
LSE
GKP
Gulf Keystone Petroleum
LSE
SOLG
Solgold
LSE
BP.
Bp
LSE
BIRD
Blackbird
LSE
POS
Plexus
LSE
GPM
Golden Prospect Precious...
LSE
HE1
Helium One Global
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved